CNR1 and Anxiety: Negative emotional states caused by Rimonabant were attributed to its action on central CB1 [140], and recent research discovered that systemic administration of the drug was able to selectively increase 2-AG and CB1 mRNA transcription in central AMY, suggesting that this brain region may have a key role in the displayed anxiety and depressive-like behaviors [141].